People

Prof. Vincent Chong ( Past President )

Dr Vincent Chong is Senior Consultant and Head of the Department of Diagnostic Imaging, National University Health System, Singapore. He graduated from the University of Malaya in 1978. He trained in Diagnostic Radiology in the University Hospitals of the University of Malaya and the University of Nottingham. He obtained his FRCR in 1984 and MBA (NUS) in 2002. Dr Chong's interest is in Head & Neck Imaging. He focuses on oncologic imaging with a special interest in nasopharyngeal carcinoma. He is a recipient or three National Medical Research Council grants (principal investigator) for nasopharyngeal carcinoma research. He has published over 90 articles, 12 book chapters, co-authored a book and edited a monograph on NPC. He is currently a member of UICC Expert Panel on Head and Neck Cancer (TNM Staging System).

Dr Chong lectures regularly. To date, he has been invited 32 times to speak in local and regional meetings where he delivered 56 lectures. He also received 58 international invitations and gave 140 lectures.

Prof. Anwar Padhani ( Past President )

Prof. Anwar R. Padhani is an internationally recognized Oncological MRI radiologist and currently, the clinical lead in MRI and head of imaging research at the Paul Strickland Scanner Centre, Mount Vernon Cancer Centre, London. He is Professor of Cancer Imaging at the Institute of Cancer Research, London. He is chairman of the executive board and Trustee of the International Cancer Imaging Society (ICIS) and its 2012 past-president. He is also a Trustee of the International Society of Magnetic Resonance in Medicine (ISMRM).

He is involved in the development of innovative research programs investigating the use of functional imaging on the microenvironment of human tumours, and has performed numerous clinical research studies evaluating tumour perfusion, permeability, oxygenation and cellularity imaging of breast, rectal and prostate cancers as well as studies of antiangiogenic and vascular disruptive treatments. This work which involves CT scanning, MRI and PET-CT is of international renown. He is a co-applicant in 20 successful grant proposals in support of this work.

He has helped establish MRI perfusion and diffusion as biomarkers of tumour response. In this regard, he has advised the National Cancer Institute of the USA and Cancer Research UK (CR-UK) on early clinical trials imaging methodology; this work has attracted clinical research organisation and pharmaceutical interest. He has been instrumental in the introduction of multiparametric prostate MRI into routine clinical practice in the UK contributing to guideline development, quality assurance programs and training.

He is a recognised cancer imaging expert looking after patients on a weekly basis. He is a specialist in a number of emerging clinical MRI applications including dynamic MRI, diffusion weighted MRI, Clinical MR spectroscopy, whole body MRI and multiparametric MRI of the prostate cancer. Recently he has expended his energy into therapy evaluations of metastatic bone disease. 

Dr. Padhani has a passion for teaching and has published chapters in 33 textbooks, 67 educational and scientific journal reviews in peer reviewed journals, and published over 117 full scientific articles in peer reviewed journals. He co-edited the book “Advances in Oncologic Imaging Techniques” (Taylor & Francis, New York) published in 2006.

Dr Padhani has given over 350 invited lectures at national and international scientific and educational medical meetings including several plenary talks and >150 post-graduate talks on multifunctional imaging, imaging of angiogenesis, advanced prostate MRI, whole body diffusion imaging and the imaging of metastatic bone disease. He has to his credit several education related awards including outstanding teacher award from the ISMRM in 2011, 2012, 2014 and honoured educator award from the RSNA in 2011 & 2014. He was the organiser of weekend educational course on “clinical MRI of cancer” at the annual meeting of the International Society of Magnetic Resonance in Medicine (ISMRM) for 2006-2009, 2010-2012.

Dr. Leslie Quint ( Past President )

Leslie E. Quint, M.D., FACR is Professor of Radiology and Surgery at the University of Michigan Health System in Ann Arbor, MI, USA. She earned her bachelor's degree from Princeton University in 1978, where she graduated Magna Cum Laude, Phi Beta Kappa, before receiving her medical degree from Cornell University in 1982. Dr. Quint completed her radiology residency training at the University of Michigan in 1986, followed by a cross sectional imaging fellowship in 1987 at the same institution. Dr. Quint is a member of the divisions of Cardiothoracic Radiology and Abdominal Radiology at the University of Michigan, Department of Radiology.

Dr. Quint has been a trustee of the International Cancer Imaging Society (ICIS) since 2007, and she is the currently the President of ICIS and the President of the Society of Body Computed Tomography and Magnetic Resonance (SCBT/MR).

Dr. Quint has co-authored more than 100 peer reviewed articles in the scientific literature, in addition to multiple book chapters and scientific abstracts. She has presented or co-authored numerous scientific papers at national and international meetings, leading to prizes from ICIS, SCBT/MR, and RSNA, and given nearly 200 extramural invited lectures. She has also received several teaching prizes and is included in the Best Doctors in America list and the Guide to America's Top Radiologists.

Dr. Quint's main clinical and research interests include CT imaging of thoracic cancers and thoracic aortic diseases. She also has a strong interest in medical education.

Prof. Dr. med Stefan Diederich ( Past President )

Stefan Diederich studied medicine at the Universities of Münster and Heidelberg, Germany and qualified in 1987. After training as a pathologist at Bochum University, Germany he started his residency in radiology in 1990 at Münster University, Germany and Addenbrookes Hospital, Cambridge, UK. He obtained his MD for a thesis on imaging of the salivary glands and his PhD for a thesis on spiral CT in pulmonary nodules.

After his board certification he was appointed staff radiologist at Münster University Hospital and later became deputy director of the department. In 2002 he was appointed chairman of the Department of Diagnostic and Interventional Radiology at Marien Hospital Düsseldorf, Germany.

Prof. Diederich' s scientific interest is oncologic imaging, particularly in the chest. 

He is member of the German Röntgen Society and was president in 2014 of the Annual German Radiology Congress and was president of the Northrhine-Westfalian Society of Radiology from 2009-2011. 

He is member of the European Society of Thoracic Imaging (ESTI), the working group chest of the German Röntgen Society. He is member of the editorial board of two scientific journals and reviewer for several further journals. He is deputy editor of Cancer Imaging and was deputy editor of European Radiology from 2011 to 2012.

He has authored and co-authored more than 110 scientific publications, 11 book chapters and given more than 300 scientific presentations and lectures in Germany, Europe and North America.

He is member of the European Society of Thoracic Imaging (ESTI), the working group chest of the G.

 

Dr. Michael King ( Past Honorary Treasurer )

Mike King qualified in medicine in 1971 and became a Fellow of the Royal College of Radiologists in 1977. In 1979, he was appointed as a Consultant at the Royal Marsden Hospital and at Westminster Hospital.
Dr. King served nine years on the Editorial Board of the British Journal of Radiology, becoming Editor in Chief between 1992 and 1995. He served as an Officer and a Member of Council for the British Institute of Radiology until 1995.

In 1996, he was elected to the Examining Board of the Royal College of Radiologists and became Senior Examiner in Final FRCR in 1999. Subsequently he has acted as External Examiner for the Royal College of Radiologists in Pakistan and Hong Kong, and joined the Examining Board of the College of Surgeons in Ireland in 2004.

Since 2006 Dr. King has been Divisional Medical Director at the Royal Marsden NHS Foundation Trust.

Dr. Liliane Ollivier ( Past President )

Liliane Ollivier studied medicine at the University of Paris and graduated in Radiology in 1979. She has been working as Senior Consultant Radiologist in the Department of Diagnostic Imaging of the Institut Curie, the cancer centre of Paris, since 1987.

Her main interest is clinical research trials and assessment of tumour response, focused on breast cancer as 80% of the patients of the Institut Curie are treated for breast cancer. She is also involved in research in breast cancer in high-risk women, geriatric oncology and global patient care in oncologic radiology.

The French Society of Radiology has recently commissioned Dr. Ollivier to lead a group on Patient Information in diagnostic imaging and radiography. This wide ranging project includes information on radiological procedures (e.g. MRI, CT, etc), contraindications, risks (radioprotection, contrast media) and the communication of results to patients.

She is a member of the French Society of Radiology (1980), became a member of the College of French Teachers in Radiology (CERF) in 2003 and President of the Radiologists of the French Cancer Centres in 2006. She was elected a Fellow of ICIS in 1999.

Professor Wolfgang Schima ( Past President )

Wolfgang Schima MD, MSc, is Associate Professor of Radiology and Chief of Radiology at the Krankenhaus Göttlicher Heiland, Vienna, Austria. He earned his medical degree at the University of Vienna, where he completed his residency in radiology at the University Hospital. In 1995 he was appointed staff member at the Department of Radiology at Medical University. He completed a research fellowship in abdominal MR imaging at the Massachusetts General Hospital and Harvard Medical School in 1995-6. In 1997 he was appointed Associate Professor and Vice Division Head of Diagnostic Radiology at the Medical University of Vienna. In 2005 he earned a Master?s Degree (MSc) in Health Care Management at the Danube University, Austria.

Dr. Schima served on the Board of Directors of the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) from 2005-2009, he has served as Executive Secretary of the Austrian Radiologic Society (ÖRG). Since 2001 he has been a member of the examining board of the Austrian Radiologic Society Society, and became Chair in 2008. He serves on the Editorial Board of European Radiology, Journal of Computer Assisted Tomography, and Cancer Imaging.

His main interest is imaging in abdominal oncology. Professor Schima has co-authored more than 100 peer-reviewed articles, 75 book chapters and review articles and has co-edited five books. He has presented more than 300 invited lectures across Europe, the USA, Asia and Africa.

Dr. Jay Heiken ( Past President )

Jay P. Heiken MD, FACR, is Professor of Radiology at the Mallinckrodt Institute of Radiology at Washington University School of Medicine, where he also is Director of Abdominal Imaging. He earned his bachelor's degree at Williams College in Williamstown, Massachusetts, where he graduated magna cum laude before receiving his medical degree from Columbia University College of Physicians and Surgeons in New York. Dr. Heiken completed his internship in internal medicine at Emory University Affiliated Hospitals in Atlanta, Georgia, and his residency in radiology at Columbia-Presbyterian Medical Center in New York. He completed a fellowship in abdominal radiology at the Mallinckrodt Institute of Radiology at Washington University School of Medicine in St. Louis, Missouri.

Dr. Heiken is a member of the Board of Directors of the Society of Gastrointestinal Radiologists (SGR) and the Board of Trustees of the International Cancer Imaging Society (ICIS). He is a past President of the Society of Computed Body Tomography and Magnetic Resonance (SCBT/MR) and has served as Chair of the Gastrointestinal Subcommittee of the Radiological Society of North America (RSNA) Scientific Program Committee. He currently serves on the American College of Radiology Committee on Body Computed Tomography. He is an examiner for the American Board of Radiology and a member of the editorial board of Abdominal Imaging and the Korean Journal of Radiology.

Dr. Heiken has co-authored more than 100 peer-reviewed articles, 60 book chapters and invited publications, and has edited and co-authored six books. He has presented scientific papers at conferences across the United States, lectured as a visiting professor in more than 40 national and international universities, and has taught more than 190 courses and symposia. Dr. Heiken has received the Cum Laude Award and the Hounsfield Award of the SCBT/MR for scientific papers. He has received the Resident's Distinguished Teaching Award from the Mallinckrodt Institute of Radiology and the Visiting Professor Award from the Society of Gastrointestinal Radiologists.
Dr. Heiken is a consultant for x-ray contrast media for Covidien/Mallinckrodt, Inc.

Prof. Robert Hermans ( Past President )

Professor Robert Hermans studied medicine at the Katholieke Universiteit Leuven, Belgium. He spent practical training periods in several hospitals in Belgium and South Africa. He was promoted cum laude to medical doctor (MD) in 1987. After his medical studies, he entered the radiology training program at the University Hospitals of Leuven, Belgium, and became certified radiologist in 1991. He was appointed staff member in the Department of Radiology at the same institution in 1992.

His main interest is head and neck radiology. In 1997, he spent a visiting fellowship in the Department of Radiology at Shands Teaching Hospital in Gainesville (University of Florida). In 1998, he obtained the degree of doctor in medical sciences (PhD) at the Katholieke Universiteit Leuven, with a thesis on laryngeal cancer imaging. He was appointed Assistant Professor in 1998, and Associate Professor in 2000, in the faculty of Medicine of the same university. In 2004, he was promoted to Professor. He has authored or co-authored over 150 published articles on head and neck imaging, and imaging of the tumoral micro environment, as well as several book chapters.

Professor Hermans edited Imaging of the Larynx and Head and Neck Cancer Imaging, both books published by Springer, Squamous Cell Cancer of the Neck, published by Cambridge University Press, and is associate editor of the Encyclopedia of Medical Imaging, published by NICER. He is invited at a regular basis to lecture in national and international radiology meetings.

Dr. Sheila Rankin ( Past President )

Sheila Rankin is Consultant Radiologist at Guy's and St. Thomas? NHS Foundation Trust in London. She graduated from Guy's Hospital and the University of London in 1972, and completed her radiology training at King's College Hospital, London, and Boston.

Dr. Rankin obtained her American Radiology Board in 1980 and became a Fellow of the Royal College of Radiologists in 1980. She has been on the editorial board of Clinical Radiology and is currently deputy editor of Cancer Imaging.

Dr. Rankin is an external examiner for FFR (Ireland), and has previously been an examiner for the Royal College of Radiologists for Parts I and II of the FRCR, and an external examiner in Hong Kong and Sri Lanka.

Her major interest is imaging in oncology, particularly related to positron emission tomography.

Prof. Jelle Barentsz ( Past President )

Jelle Barentsz is Professor of Radiology and Vice-chairman for Research in the Department of Radiology of the University Medical Center Nijmegen, The Netherlands. He received his MD cum laude from the University of Utrecht in 1980, and obtained his PhD in medical research in 1990 on MR imaging of the urinary bladder. He is a recognized expert and well known speaker in MR imaging of urogenital and pelvic diseases as evidenced by numerous peer reviewed publications and invitations for presentations at most international meetings.

Dr. Barentsz's future research focusses on new functional and molecular imaging techniques in oncology (especially prostate, breast, bladder, colorectal, and cervical cancer). He has a special interest in new developments in magnetic resonance and contrast agents, and in the fusion of the new functional imaging techniques such as dynamic MRI, MRS, CT, and PET. Central to this research is the value added to patient care of combined new imaging techniques and benefits to the health care system in general.

The highlight of his scientific career is illustrated with the SCBT&MR Lauterbur Award in 1999, senior author of the SCBT&MR In-training Award 2003, two SCBT & MR cum Laude Awards in 2004 and 2008, and six First Price awards (1994, 1998, 2001, 2002, 2006, 2007) from the Society of Uroradiology.

Dr. Barentsz's organizational capacities are demonstrated by his position as Founding Member and President of the International Cancer Imaging Society in 2005, President of the European Society of Urogenital Radiology from 2002-2004, and his Chairmanship of the Scientific Exhibits Committee of the European Congress of Radiology from 1999-2002.

Professor Barentz has been the recipient of many major awards, including four from the SCBT & MR and six First Price Awards from SUR. His major grants include a €2m Program Award from the Dutch Cancer Society (2007-2013) to explore the clinical value of novel high resolution anatomic and molecular/functional MR imaging in prostate cancer.

Dr. Barentsz is a well-known and frequently invited speaker on MRI of urogenital diseases and on MR-contrast agents. He presents over 20 invited lectures at numerous international meetings every year. He is Section Editor EURORAD Female Pelvis, has published over 160 journal articles and has an h-index of 32.

Prof. Massimo Bellomi ( Past President )

Professor Bellomi is Director of the Department of Radiology at the European Institute of Oncology and Associate Professor of Radiology of the School of Medicine, University of Milan. He lectures in radiology at the School of Medicine and is Director of the postgraduate school of radiology and faculty for the teaching of radiology in 15 University of Milan postgraduate medical schools.

In the last five years he has organized 12 national and international courses and meetings. He is member of SIRM, EAR, ESR, ICIS (being president in 2003-04), ESGAR and ESTI.

Professor Bellomi's scientific activity is focused on cancer imaging; he is principal investigator in 11 clinical trials and author of 143 scientific papers and 260 presentations (190 published in abstract).

Prof. Daniel Vanel ( Past President )

Professor Daniel Vanel is based at The Rizzoli Institute, Bologna, Italy. His research interest is imaging musculo-skeletal tumours.

Prof. Rodney Reznek ( Past President Editor Emeritus of Cancer Imaging , Founder )

Professor Reznek graduated with honours from the University of Cape Town in 1972, became a Fellow of the Royal College of Radiologists in 1980 and a Fellow of the Royal College of Physicians in 1990. He is the author or co-author of over 200 publications. He is a past Editor-in-Chief of Clinical Radiology, Section Editor of European Radiology, Editor of Cancer Imaging and on the editorial board of two other journals. He is co-founder and Past President of the International Cancer Imaging Society. He has served on the Education and Faculty Boards of the Royal College of Radiologists and been chairman of the Scientific Programme Committee. He has held Visiting Professorships in several countries and given eponymous lectures in the USA, China, and the UK.

Prof. Dame Janet Husband DBE ( Past President Founder )

Professor Janet Husband and Professor Rodney Reznek founded the International Cancer Imaging Society in 1998. Professor Husband was the first President of the Society. She has recently retired as Head of the Department of Diagnostic Radiology at the Royal Marsden Hospital and Institute of Cancer Research, Sutton, Surrey. Since her appointment in 1980 she led pioneering clinical research both in CT and MRI in cancer care. Professor Husband has published over 200 scientific papers and books, and lectured extensively throughout the world. A Personal Chair of Diagnostic Radiology was conferred upon her by the University of London in 1996. In 2002 Dame Janet was awarded an OBE in recognition of her contribution to cancer imaging in the Her Majesty the Queen's Birthday Honours. She continued to pursue excellence in the development of radiology and oncology as a high quality service for patients, in education and in promoting research nationally and internationally for the benefit of patients, and in the Queen's Birthday Honours 2007, was appointed Dame Commander of the Most Excellent Order of the British Empire for services to medicine.

Prof. Gina Brown

Prof .Anju Sahdev ( President Elect )

Prof. Dr. med Stefan Delorme

Dr. Rosemarie Forstner

Prof. Isaac Francis

Prof. Richard Gore

Prof. Christian Herold

Prof. Rodney Hicks ( Joint Editor-in-Chief, Cancer Imaging )

 Rod Hicks is a Professor of Medicine and Radiology at the University of Melbourne and Director of the Centre for Cancer Imaging at the Peter MacCallum Cancer Centre in Melbourne, Australia. Peter Mac installed the first PET/CT outside Europe and North America in December 2001 and now has an experience of over 60,000 PET studies performed in the facility founded by him in 1996.

He has pioneered the use of this modality in the assessment of cancer and is recognized as an international leader in this field. His group has introduced a number of novel imaging techniques that provide enhanced diagnosis and evaluation of cancer behaviour. Professor Hicks’ group established the first small animal PET imaging facility in Australia in 2002 and has a strong focus on translational research and drug development. His group has also been involved in the Commonwealth of Australian-funded Cooperative Research Centre for Biomedical Imaging Development as a core partner. Professor Hicks was its radiopharmaceutical stream leader.

He holds numerous national and international research grants, is on 8 editorial boards, has published over 300 peer-reviewed articles and more than 15 book chapters. A major focus of his clinical research has been to assess the impact of PET on patient management and prognostic stratification. In addition, he is actively involved in radionuclide therapy with a major focus on neuroendocrine tumours and treatment of neuroblastoma in children.

Dr. Hedvig Hricak

Prof. Thierry Huisman ( Vice President , MD. PD, FICIS, FGNS, FASPNR, FACR )

Thierry A.G.M. Huisman is the current Radiologist-in-Chief and TCH Chair of the Department of Radiology at Texas Children’s Hospital in Houston, USA. He also holds the Edward B. Singleton Chair of Radiology. He is a tenured Professor of Radiology, Pediatrics, Neurosurgery, Neurology, Obstetrics and Gynecology at Baylor College of Medicine and holds adjunct Professor Appointments at Johns Hopkins School of Medicine in Neurosurgery and Pediatrics. Before he joined TCH he served 11 years at Johns Hopkins Medicine in Baltimore. He was the Chairman of the Department of Imaging and Imaging Science at the Johns Hopkins Bayview Medical Center. In addition, he was the Director of the Division of Pediatric Radiology, Director and founder of the Division of Pediatric Neuroradiology at the Johns Hopkins Hospital in Baltimore and Co-Director of the Neurointensive Care Nursery (NICN), the Johns Hopkins Fetal Program and the Center for Translational and Molecular Imaging (CTMI). Prior to his tenure at Johns Hopkins he was the Chairman and Radiologist-in-Chief of the Department of Diagnostic Imaging at the University Children’s Hospital Zurich. He graduated cum laude from Medical School at the Erasmus University in Rotterdam, the Netherlands, before completing residencies in Radiology and Pediatrics and fellowships in Pediatric Radiology and Neuroradiology at the University Hospital Zurich, Switzerland. Dr. Huisman enjoyed a 2.5-year research sabbatical at the Massachusetts General Hospital NMR center, Harvard Medical School in Boston. His primary field of expertise and research focuses on advanced, quantitative, precision imaging in the field of Neuroradiology. He has given more than 480 invited lectures, published 430 articles and 31 reviews, 67 book chapters, 6 text books, serves on multiple scientific committees of the various radiological societies and has organized multiple national and international meetings in Europe and the USA. He has been one of the founding members of the Swiss Symposium in Pediatric Neuroradiology and the Neurointensive Care Nursery at Johns Hopkins. Dr. Huisman served as a faculty member of the AIRP course in Washington, DC (2013-2019), and is a course advisor for the IDKD course in Davos, Switzerland since 2012. Furthermore, he has built several patient and family focused multidisciplinary programs and is actively involved in mentorship programs. He is a reviewer for multiple scientific journals and is an editorial member of 5 journals. He served as president of the American Society of Pediatric Neuroradiology (2014/15) and the Eastern Neuroradiological Society (ENRS) (2020/2021), is a fellow of the International Cancer Imaging Society, the Global Newborn Society, the American College of Radiology, and the American Society Pediatric Neuroradiology. He is the elected President of the International Cancer Imaging Society, 2024-2025. Finally, he served as senior editor of the American Journal of Neuroradiology 2015-2023.

Prof. Dow-Mu Koh ( Past Honorary Treasurer )

Prof. Dow-Mu Koh, MD., M.R.C.P., F.R.C.R.
Professor in Functional Cancer Imaging, 
Consultant Radiologist in Functional Imaging
Royal Marsden Hospital, Sutton, UK

Prof. Koh obtained his primary medical degree in Singapore (1989).  Following further training in internal medicine and diagnostic radiology, he was awarded the fellowship of the Royal College of Radiologist (UK) in 1996. He was appointed to the position of Consultant Radiologist in Functional Imaging at the Royal Marsden Hospital in January 2008 and was conferred the title of Professor in Functional Cancer Imaging at the Institute of Cancer Research in 2015. 

Prof. Koh’s current clinical and research interest is in the development and application of functional imaging techniques for tumour assessment. He has a particular interest in developing and evaluating diffusion-weighted MR imaging in the body (DWI), to enhance and improve the ability to detect and characterise tumours, as well as to monitor the effects of conventional and novel therapeutics. 

Prof. Koh is the Imaging Theme Lead for the National Institute of Health Research (NIHR) Biomedical Research Centre at the Royal Marsden Hospital and Institute of Cancer Research. In 2015, he was appointed a member of the National Cancer Research Institute (NCRI) Imaging Biomarker Advisory Board in the UK. 

In addition to his research, Prof. Koh lectures regularly at numerous conferences and courses, including the European Congress of Radiology (ECR), European School of Radiology (ESOR), European Society of Gastrointestinal and Abdominal Radiology (ESGAR), International Society of Magnetic Resonance in Medicine meetings (ISMRM) and the Radiological Society of North America (RSNA) meetings. He was named outstanding teacher by the ISMRM in 2008, 2009 and 2012. 

Prof. Koh was elected a Fellow of the International Cancer Imaging Society (ICIS) (2007) and appointed Honorary Treasurer of the Society in 2011. He is series organiser for the ICIS interactive courses, a hands-on teaching course; and also the course organiser of the Body DWI course on behalf of the ESMRMB School of MRI. 

Prof. Koh is currently an associate editor for Radiology, and also reviews regularly for other radiological and medical journals. He was awarded the Barclay Medal in 2013 for his contributions to the British Journal of Radiology. Prof. Koh has had numerous publications in peer reviewed journals and textbooks.  In 2009 he co-edited a book, ‘Diffusion-weighted MRI: Applications in the Body’, published by Springer.

 

Prof. Olivier Lucidarme ( Immediate Past President )

Dr. David MacVicar

Prof. Luis Marti-Bonmati

LUIS MARTÍ-BONMATÍ MD, PhD, BIOSKETCH

After graduating in Medicine (University of Valencia, 1978-1983) with the Extraordinary Graduation Prize, and completing his postgraduate training as a resident in Radiology (1984-1987), Dr. Martí-Bonmatí obtained his Doctoral Thesis (PhD) with his work on magnetic resonance imaging in liver tumors (Cum Laude, 1991). In 1995 he became Section Chief of Magnetic Resonance Imaging in the Radiology Department of Dr. Peset University Hospital (Valencia). Since 1997 he serves as Head of the Radiology Department at Quirón Hospital in Valencia, integrating biomedical engineering in the radiological innovation process in that center. In 2009, Dr. Martí-Bonmatí became Chairman of the Radiology Department and Director of Medical Imaging at La Fe University and Polytechnic Hospital, Valencia. That same year he was designated as Radiology coordinator of the Catholic University in Valencia, and in 2011 became Professor of Radiology and supervisor at the University of Valencia. He has been the Director of 49 Doctoral Thesis and End of Career Projects.

Since 2012, Dr. Marti-Bonmatí has been the Director of the Research Group on Biomedical Imaging (GIBI230) within La Fe Health Research Center, an institution belonging to the Spanish Research Network at the Spanish Ministry of Science and Technology. The group focuses on radiomics, imaging biomarkers and structured radiology, together with preclinical animal imaging experiments. He has co-founded QUIBIM (Quantitative Imaging Biomarkers in Medicine, QUIBIM), an innovative spin-off company dedicated to medical image processing, extraction and measurement of imaging biomarkers for clinical diagnostics, research projects and clinical trials.

In relation to his academic activities, mention should be made of his nomination as academic member of the Spanish Royal National Academy of Medicine (2015, in representation of Radiology). He has also received an Honorary Doctorate Distinction from the National University of Tucumán, Argentina (2015).

Dr. Martí-Bonmatí is a member of the Spanish National Radiodiagnosis Commission (since 2014), and has been Chairman of the following societies: the European Society of Magnetic Resonance in Medicine and Biology (ESMRMB), the Spanish Society of Radiology (SERAM, being awarded the Gold Medal of the SERAM in 2014), the Spanish Society of Abdominal Radiology (SEDIA, founder and Editor of its journal, Radiología Abdominal from 2004-2013), and the European Society of Gastrointestinal and Abdominal Radiology (ESGAR). In ESGAR, he has served also as President of the Annual Meeting Scientific Committee for Prague and Athens (2016-2017). He is also a fellow of the International Cancer Imaging Society (ICIS) and Director of the Association for the Development and Investigation of Medical Radiology (ADIRM), a non-profit institution developed to enhance the development of medical imaging by using the resources of local Universities and research groups.

Dr. Marti-Bonmati has been a member of the Executive Council and has served as Director of the Research Committee of the European Society of Radiology (ESR) from 2010 to 2013, starting the Imaging Biomarkers Subcommittee, and representing Radiology in the European Council for Health Research at the Alliance for Biomedical Research in Europe (biomedeurope.org). He is currently a member of the European Imaging Biomarkers Alliance (EIBALL) and of the Scientific Council of the European Institute of Biomedical Imaging Research (EIBIR). He has given a “Ramón y Cajal” Honorary Lecture on “Research and science: from individuals to societies” on occasion of the European Congress of Radiology (2013), in recognition of his research activity.

The candidate is a lecturer and course organizer of the European School of Radiology since 1997, and a member of its Steering Committee since 2015.

He has been a member of the Council and General Secretary of the International Society of Radiology (2014 to 2016). He is also member of the Economic Committee (since 2013) and Regional Europe Committee (since 2016) of the Radiological Society of North America.

In 2008, Dr. Martí-Bonmatí has received the European Magnetic Resonance Award of the European Magnetic Resonance Forum (EMRF) for his investigations in MRI. He has also received the Pro-Academia Prize in 2013 for “Exemplary group in Science and Academic life” of the the Round Table Foundation and the European Magnetic Resonance Forum. In 2014 he was awarded the Teleco Honoris Causa Prize from the Official College of Telecommunications Engineers of the Valencian Community.

Dr. Martí-Bonmatí has been Associate Editor of European Radiology (Magnetic Resonance) and Radiology (Computer Applications). He has also been a member of the Editorial Board of the journals Cancer Imaging and Diagnostic Imaging Europe. He is currently the Editor-in-Chief of Insights Into Imaging.

Dr. Martí-Bonmatí is the author of over 498 publications (262 of which are indexed in Medline), the Editor of 12 books, and the author of 57 book chapters. Most of his publications focus on Magnetic Resonance, Clinical Radiology, the development of Imaging Biomarkers, and Engineering-supported Biomedical Research.

He holds 10 patents and software registries, with two more in process.

The candidate has actively participated in 43 financed research projects, with a global budget of more than 42 million €. He has been the Principal Investigator in 14 of these projects, with a total financial support of 33 million €.

Luis Martí-Bonmatí has a Hirsch h-index of 38 (ResearchGate, March 2018). The mean ratio is 12 citations per article and 127 citations per year (Web of Science, January 2018). His Research Gate Score is 44.98 (97.5% percentile Research members, March 2018).

His special areas of interest are imaging biomarkers, image processing, imaging biobanks, abdominal imaging, and clinical management in radiology.

Dr. Beth McCarville ( Honorary Secretary )

Beth McCarville MD, is a paediatric radiologist and Associate Member of the Department of Radiological Sciences at St. Jude Children’s Research Hospital in Memphis, Tennessee. She obtained her bachelor’s degree, with honours, at the University of Iowa in 1986 and her medical degree from the University of Iowa in 1990. She completed her residency in diagnostic radiology at St. Louis University in 1994 followed by a one-year fellowship in paediatric radiology at the Hospital for Sick Children in Toronto, Ontario, Canada.

Dr. McCarville is Chair of the Exhibits Committee for the Society for Pediatric Radiology, Chair of the Neurosonology Community of Practice for the American Institute of Ultrasound in Medicine, Chair of the Radiological Sciences Protocol Review Committee at St. Jude Hospital and serves on the Editorial Board of Pediatric Radiology. She also serves on the National Cancer Institute, Cancer Imaging Steering Committee and is a Special Government Employee, serving on the Medical Imaging Drugs Advisory Committee for the Federal Drug Administration. She was elected a Fellow of ICIS in 2006.

Dr. McCarville’s research interests focus on imaging of solid tumours in children. She has received grant funding and industry support for studies of contrast-enhanced ultrasonography in children with cancer and the role of PET-CT in the assessment of pulmonary nodules in children with solid malignancies. She is a central reviewer for National Cancer Institute funded studies of hepatoblastoma and non-rhabdomyosarcoma soft-tissue sarcomas that are being conducted by the Children’s Oncology Group.

Dr. McCarville has authored more than 100 peer-reviewed papers, numerous book chapters and is currently co-editing a book on paediatric tumours. She has given over 60 invited lectures nationally and internationally. She has received the Caffey Award for best basic research from the Society for Pediatric Radiology as well as several Certificates of Merit for scientific exhibits. She is recognized in Best Doctors in America.
 

Dr. Kieran McHugh

Dr. Theresa McLoud

Prof. Giovanni Morana (Treviso) ( Past President )

1986: Medical Doctor degree University of Catania 
1992: Specialization in Radiology University of Verona
From October 1988 to September 2004: Clinical Staff Member in the Department of Radiology of the University of Verona.
From September 2004: Chief of the Radiological Department of the Treviso General Hospital.

He was habilitated for full Professorship in Radiology in 2014.
Member of Italian Association of Medical Radiology, European Society of Radiology, Radiological Society of North America, European Society of Gastrointestinal Radiology, International Society for Magnetic Resonance in Medicine.
He is in the Editorial Board of “Radiologia Medica” since 2006 and “Radiology of infectious diseases” (2015-2017).
He is reviewer for “Radiologia Medica”, “Eurorad”, “European Radiology”, “European Journal of Radiology”, “World Journal of Hepatology”, “Cancer Imaging”, “Abdominal Imaging”. He has been involved in the Scientific Committee of ECR from 2005 up to 2010.

He has been meeting president of the 22nd annual meeting of the European Society of Gastrointestinal and Abdominal Radiology (ESGAR), Venice, May 21-24, 2011.
He is President of the Regional Committee (Veneto and Trentino-Alto Adige) of the Italian Society of Radiology (SIRM), 2013-now.
He has published 60 papers, 25 chapters of book, 82 abstracts and 36 posters.
His posters have been prized in several international meetings (ECR 2000, ECR 2001, ESGAR 2001, ECR 2002, ICIS 2013).
He has been given more than 250 lectures either in national and international meetings.
He has organized several meetings mainly focused on body MR and Gastro-intestinal imaging.

 

Prof. Dr. Matthijs Oudkerk

Prof. Dr. Wim J. G. Oyen ( Past President )

The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK

Wim Oyen trained in medicine at Radboud University Nijmegen, Netherlands, obtaining his MD in 1988. After receiving a PhD from that university in 1992, he trained in clinical nuclear medicine,becoming a consultant at Radboud University Medical Center (RadboudUMC) in 1995. He was appointed full Professor of Nuclear Medicine at the Radboud University in 2001. Professor
Oyen served as Head of the Department of Nuclear Medicine and Director of the Research Institute for Oncology of RadboudUMC. In September 2015, he was appointed Professor of Professor of Nuclear Medicine and Molecular Imaging at The Institute of Cancer Research and Head of the Department of Nuclear Medicine of The Royal Marsden NHS Foundation Trust, London, UK.

Professor Oyen’s main research interests are molecular imaging and radionuclide therapy of cancer. He is the (co-)author of more than 575 original science and review articles in international peer-reviewed journals. He is currently actively involved in the European Association of Nuclear Medicine, the European Cancer Organisation, and the European Organisation for Research and Treatment of Cancer.

Professor Oyen also serves as Associate Editor of The Journal of Nuclear Medicine and is a member of the Editorial Board of the European Journal of Nuclear Medicine and Molecular Imaging.

Dr. Caroline Reinhold

Prof. Andrea Rockall ( Past President )

Andrea Rockall graduated from King’s College Hospital, London in 1990 and trained in radiology at St Mary’s Hospital and University College Hospital, London. She was appointed as Senior Lecturer in Diagnostic Imaging at Queen Mary University of London and Honorary Consultant Radiologist at Barts and The London NHS Trust in 2000 and became Professor of Cancer Imaging in 2009. She has a special interest in gynaecologic and urologic imaging as well as machine learning in cancer imaging. She has recently taken up the position of Clinical Chair of Radiology, Imperial College London.  

Prof. Dr. med Heinz-Peter Schlemmer ( Past President )

Heinz-Peter Schlemmer is Professor of Radiodiagnostic Oncology at the Medical Faculty of the University of Heidelberg, Head of the Radiology Department, and Coordinator of the Research Program “Imaging and Radiooncology” at the German Cancer Research Center.

Professor Schlemmer is both a Physicist and Radiologist, and for many years has been actively involved in the development and clinical application of novel imaging technologies in oncology. During his career as a physicist he was engaged in basic research in nuclear magnetic resonance in physics and biophysics at the Max-Planck-Institute for Medical Research in Heidelberg.

Following his academic studies in medicine and his residency in Radiology at several national and international University hospitals, his research has focused on the development and clinical applica-tions of novel MR methods in oncology. His particular research interests include morphological and functional MR imaging and spectroscopy at conventional 1.5 T up to ultra-high 7.0 T magnetic field strengths, dual-energy CT, PET/CT and PET/MRI.

His scientific interest is currently focused on particular tumour entities: prostate cancer, lung cancer, multiple myeloma and malignant melanoma. Clinical and scientific activities are performed in close cooperation within the Imaging and Radiooncology Research Program and Departments of Ra-diology, Neuroradiology, Nuclear Medicine and Radiooncology at the University of Heidelberg Hospital, including joint support at the National Center for Tumour Diseases (NCT) in Heidelberg.

The Department of Radiology at the DKFZ is partner within the National Consortium of Translational Oncology and therefore involved in coordinated research activities of several University partners in Germany. In addition, active collaborations exist with medical-technical and pharmaceutical industry partners for sustained development of novel imaging methods.

Dr. Lawrence Schwartz

Dr. Aslam Sohaib ( Past President )

Dr Aslam Sohaib BSc MBBS MRCP FRCR

Consultant Radiologist , Royal Marsden Hospital, London, UK

Dr Sohaib gained his medical degree from Guy’s Hospital Medical School, London in 1990 and then obtained his general medical training in Cambridge. He undertook specialist training in diagnostic radiology at St Bartholomew’s and the Royal London Hospital. He was appointed as a Consultant Radiologist at The Royal Marsden in 2000 and is currently the Clinical Director for the imaging related services at the Hospital.

Dr Sohaib has been extensively involved in teaching and training. He was the lead (2002-2016) for radiologist sub-speciality training in oncological imaging. He has lectured on many courses and is one of the organisers for the ICISi courses.

Dr Sohaib has published widely on a variety of topics related to cancer imaging having authored or co-authored over 100 peer reviewed publications. His major research interest is related to the use of CT and MR imaging in patients with genito-urinary malignancies.

Prof. Harriet C. Thöny ( Past Honorary Secretary )

Dr. Ronald Castellino

Prof. Herman I. Libshitz

Dr. Sanjay Saini

Ken Miles ( Past Honorary Editor )

Ken Miles is dually accredited in Radiology and Nuclear Medicine having undergone specialist training at Leicester and Cambridge UK. Obtaining his MD for a thesis on imaging of tissue perfusion with CT, he has subsequently pioneered the use of perfusion CT in oncology.

Ken has previously held clinical and academic posts in the UK and Australia. Currently, he undertakes clinical work in Radiology and Nuclear Medicine in Australia whilst his academic work is based at University College London, UK where he holds the position of Professorial Research Associate in the Institute of Nuclear Medicine. He is also Clinical Director of TexRAD, a company that is developing texture analysis software to provide imaging biomarkers for oncology.

The educational roles that Prof Miles’ has undertaken include the development of a novel imaging curriculum for undergraduate medical students, establishment of a curriculum in cross-sectional imaging for specialist trainees in Nuclear Medicine, and national and international invited lectures.

Ken’s scientific interests lie in the functional imaging of tumours, ranging from the development of new techniques through to demonstrating cost-effectiveness.

He has wide experience in Positron Emission Tomography, having been involved in the establishment of three PET centres worldwide and recently completing a term as co-lead of the UK National Cancer Research Institute’s PET Research Network. He has authored or co-authored more than 100 peer-reviewed scientific publications and contributed to or edited 11 books in Radiology.

Dr. Jonathan Goldin

Dr. Anne Smets

Prof. Conor Collins ( Past Honorary Secretary )

Conor Collins qualified in Medicine (University College, Dublin and St. Vincent’s University Hospital) and following radiology training in Dublin and London was appointed as consultant radiologist to Christie Hospital NHS Trust, Manchester and hon. lecturer in radiology, University of Manchester. His current appointment is consultant radiologist at St. Luke’s Hospital and St. Vincent’s University Hospital, Dublin and Assoc. Professor, University College, Dublin.

His main interest is Oncology Imaging particularly the role of  PET CT in the diagnosis, staging and assessment of treatment response in cancer. He has published over 60 articles and chapters as author and co-author in addition to giving numerous invited lectures.  He is a past Hon. Secretary of ICIS and is a current trustee and member of the executive board of ICIS. 

Dr. Jeong Min Lee

Dr. Sarah Vinnicombe

Prof. Dr. Markus Schwaiger

Prof. Giuseppe Petralia

Prof. Evis Sala

Evis Sala is the Professor of Oncological Imaging at the University of Cambridge, United Kingdom (UK) and co-leads the Cancer Research UK Cambridge Centre Advanced Cancer Imaging Programme and the Integrated Cancer Medicine Programme.

Dr Sala’s research focuses on the development and validation of functional imaging biomarkers to rapidly evaluate treatment response using physiologic and metabolic tumour habitat imaging. Her research in the field of radiogenomics has focused on understanding the molecular basis of cancer by demonstrating the phenotypic patterns which occur as a result of multiple genetic alterations that interact with the tumour microenvironment to drive the disease in several tumour types. Her work integrates quantitative imaging methods for evaluation of spatial and temporal tumour heterogeneity with genomics, proteomics and metabolomics. She is also leading multiple research projects focusing on the development and implementation of artificial intelligence methods for image reconstruction, segmentation, and data integration. Dr Sala is an outstanding educator, orator and mentor. In recognition for her contribution to education and research in oncological imaging she received the Radiology Society of North America (RSNA) Honoured Educator Award in 2014, 2017 and 2020. Her leadership extends to the most important international bodies in the field, as Fellow of the International Cancer Imaging Society, Fellow of the International Society for Magnetic Resonance in Medicine and Fellow of the European Society of Urogenital Radiology. 

Dr. Alexander Towbin

Dr. Hersh Chandarana

Dr. Chandarana is a tenured Professor of Radiology, Associate Chair for Clinical and Translational Research, and physician-scientist in the Department of Radiology at the New York University Grossman School of Medicine. Dr. Chandarana has interest and experience in the development and application of advanced imaging techniques to study pathophysiology of abdominopelvic diseases, with special interest in oncologic imaging. His extensive and productive collaborative efforts with clinicians and basic scientists as well as industry scientists allows him to collaboratively address important clinical problems. 

Dr. Kartik Jhaveri

Dr. Kartik S. Jhaveri, MD FRCPC is the Director of Abdominal MRI and Faculty Abdominal Radiologist in the Joint Department of Medical imaging of the University Health Network, Mount Sinai Hospital and Women’s College Hospitals. He is also the Director of Continuing Education for the Dept. of Medical Imaging of the University of Toronto and has received multiple teaching awards by the University of Toronto residency and fellowship programs. He is currently an Associate Professor at the University Of Toronto Faculty Of Medicine.

He has focused clinical and research interests in the field of Abdominal MRI. He has lectured internationally including at the Radiological Society of North America and International Society of Magnetic Resonance in Medicine.He also leads multiple grant funded research initiatives in body MRI. His areas of clinical and research expertise are focused on hepatobiliary diseases, renal and rectal cancer. He has authored several peer reviewed publications, book chapters, clinics and scientific presentations.He serves on International and North American radiology organization committees such as RSNA, ISMRM, Society of Abdominal Radiology, and Society of Computed Body CT-MR. He has also served on research committees of the Society of Abdominal Radiology and SCBT-MR. He has been an Assistant Editor on the Editorial Board of the American Journal of Roentgenology. He has been nominated and invited as a fellow of the International Cancer Imaging Society as well as many other North American Imaging Societies.

 

Prof. Ann King

Prof. Jurgen Futterer

Jurgen Futterer is an associate professor at the Radboudumc and the University Twente (MIRA). His role focuses on imaging techniques in prostate cancer, with particular interest in functional magnetic resonance imaging (MRI) techniques and MRI-guided interventions, such as MRI-guided laser-ablation, cryosurgery, and focused ultrasound surgery. Dr Futterer qualified at Radboud University Nijmegen in 2001, and completed his PhD on MRI techniques in the localisation and staging of prostate cancer in 2006. He was a radiology resident at the University Medical Centre, Nijmegen, in 2003, and completed a fellowship in interventional radiology/body MRI in 2009. Dr Futterer is co-principal investigator of an international, multicentre study—the PCa-MAP trial—to investigate multi-modality MRI of the prostate in localising prostate cancer, and has published extensively on MRI in prostate cancer in various journals and books chapters. He has also introduced a robotic device for MRI-guided biopsy of the prostate, which has been established as a novel prostate intervention.

 

Dr. Marius Mayerhoefer

Dr Hebert Alberto Vargas

Dr. Alexandra Athanasiou

Dr. Giovanni Morana (Turin)

Prof. Mirko D'Onofrio

Dr. Luigi Grazioli

Department of Radiology, Spedali Civili di Brescia, University of Brescia Italy

Luigi Grazioli was born in 1958 and received his MD degree with full honours at the University of Brescia (Italy) in 1985. He was then a resident at The Department of Radiology at The University of Brescia and became a radiologist in 1990. Since his residence experience, one of his main fields of interest has been the clinical application of MRI and CT in gastrointestinal and urogenital diseases. Growing MRI and CT experience led to specialization in liver and pancreatic diseases in terms of diagnosis and interventional radiology.  

From 1998 to 2000, Dott.Grazioli was a visiting fellow at the Department of Radiology, Abdominal Imaging Section, University of Pittsburgh, PA (USA) to develop his knowledge in the hepatobiliary imaging field. He is currently chief of the First Department of Radiology at Spedali Civili di Brescia - University of Brescia

Dott. Grazioli is a member of SIRM (the Italian Society of Radiology), the European Society of Radiology (ESR), the European Society of Gastrointestinal and Abdominal Radiology (ESGAR), the International Cancer Imaging Society (ICIS) and the Radiologic Society of North America (RSNA). Since 1994 he has collaborated in many research projects as either principal investigator or co-investigator (including more than 50 study trials, of which five are in progress). Many of these studies concern the clinical application of different contrast agents in liver MRI. He has authored many publications in both Italian (107) and International journals (63) abstracts excluded and is co-editor of the books “MRI of the Liver” (Springer Editor, Milan 2002), “MRI of the Liver”, Second Edition (Springer Editor, Milan 2006), and ”Imaging of urogenital diseases” (Springer Editor, Milan 2009).

Prof. Bernhard Gebauer

Mr. St. John Brown ( Past Honorary Treasurer )

StJohn Brown spent 16 years with GE and then Philips Medical businesses, in Hong Kong, Singapore, and the Netherlands. He returned to the UK in 2001 where he was involved in founding and setting up a number of out patient centres including United Open MRI (the first weigh bearing MRI scanner in London), and Nuada Medical who installed the first private 3T MRI scanner in the Harley Street area. He is Chairman of Medical Imaging Partnership Ltd, Vice Chairman of London Orthopaedic Imaging Ltd, and a Trustee of the International Concussion and Head Injury Research Foundation. In his early career he worked for Citibank NA and the Boston Consulting Group and has an MA from Oxford University.

Prof. Annick D. Van den Abbeele ( Past President )

Annick D. Van den Abbeele, MD, FACR, FICIS

Professor Van den Abbeele is Professor of Radiology at Harvard Medical School; Chair Emeritus, Department of Imaging, Founder and Director of the Center for Biomedical Imaging in Oncology, Dana- Farber Cancer Institute; Co-Director of the Tumor Imaging Metrics Core, Dana-Farber/Harvard Cancer Center; Chief Emeritus, Division of Cancer Imaging, Department of Radiology, Mass General Brigham; and Senior Faculty Scholar, Dana-Farber Cancer Institute and Mass General Brigham.

Professor Van den Abbeele was recently elected the 2021-2022 President of the International Cancer Imaging Society (ICIS) and serves as co-Editor-in-Chief of the ICIS journal, Cancer Imaging. She is nationally and internationally known for her translational research in molecular imaging, building upon her pioneering work in using imaging to monitor target hit and response to molecularly-targeted therapy and immunotherapy in several cancers. Professor Van den Abbeele is the founder and director of the Center for Biomedical Imaging in Oncology, an integrated clinical and preclinical cancer imaging center co-located with a research-dedicated state-of-the-art cyclotron. She also co-founded and co- directs the Tumor Imaging Metrics Core now established at eight national comprehensive cancer centers. Professor Van den Abbeele has participated in multiple trials testing novel diagnostic and therapeutic agents and helped implement the field of theranostics in multiple cancers. She launched cancer imaging as a new imaging specialty, and the Cancer Imaging Program Fellowship which has grown from one fellow to nine fellows currently who are themselves creating cancer imaging divisions in their own departments.

Her major areas of research include translational cancer research using molecular imaging using multidisciplinary integrated pre-clinical and clinical programs, and quantitative tumor imaging metrics. Professor Van den Abbeele is a Fellow of the American College of Radiology (FACR) and of the International Cancer Imaging Society (FICIS). She has received several awards, serves on various national and international scientific advisory boards and review panels, NCI program progress review groups, and several local, national and international committees. Professor Van den Abbeele has mentored over 200 trainees; serves as a PhD thesis advisor, reviewer and faculty mentor; has authored and co-authored more than 300 scientific articles, abstracts, educational materials, book chapters; co- edited 2 textbooks; and presented numerous lectures and workshops nationally and internationally.

Dr. Khaled Elsayes

Prof. Pek-Lan Khong ( President )

Prof. Gabriele Masselli

Prof. Rozemarijn Vliegenthart

Rozemarijn Vliegenthart (MD, PhD, EBCR, FNASCI, FICIS) is Radiologist and Professor of Cardiothoracic Imaging at the University Medical Center Groningen, The Netherlands. Her clinical and research interests focus on early detection and screening of cardiothoracic diseases, in particular lung cancer, COPD and cardiovascular disease (the Big-3). Vliegenthart has obtained a number of grants in cardiothoracic imaging as applicant or co-investigator. She is PI of the B3care project, in which an imaging biobank is created to validate AI algorithms for Big-3 imaging biomarkers, as well as PI of the ImaLife study and of the CONCRETE trial. Vliegenthart is (co-)author of 235 papers (H index 44), and is Associate Editor of the European Journal of Radiology and the Journal of Cardiovascular Computed Tomography. She has held invited lectures at numerous international conferences including ICIS, WCLC, ECR and RSNA. 

 

Professor Dr. med. Thomas Henzler

Thomas Henzler is an attending radiologist and Associate Professor of Radiology at
the University Medical Center in Mannheim of the Heidelberg University in Germany.
Dr. Henzler is the head of cardiothoracic radiology and computed tomography as well
as head of research within his institution. He focuses of functional CT imaging in
cardiovascular disease and oncology. Dr. Henzler is also a group member of the
German Center of Cardiovascular Disease (DZHK).

 

Dr Stephanie Nougaret

Dr. Luba Frank

Prof. Arturo Chiti

Dr Mizuki Nishino

Dr Gigin Lin

Prof Nicola Sverzellati

Dr. Nickolas Papanikolaou

Nickolas Papanikolaou, PhD (Male), is a Principal Investigator in Oncologic Imaging at CHAMPALIMAUD FOUNDATION and research group leader of the Computational Clinical Imaging Group. He is an Affiliated Researcher at Karolinska Institute and a Senior Affiliated Researcher at the Institute of Computer Science – FORTH. Dr. Nikolaos Papanikolaou studied biomedical engineering while he obtained his Ph.D. from the Medical School of the University of Crete. He has been a research associate of the Department of Radiology, University Hospital of Heraklion, from 1999 to 2009.

He has published 85 scientific papers in peer-reviewed international journals, 17 chapters in international books. At the same time, he edited a series of 3 books on Diffusion-Weighted Imaging Applications in GI, GU, and Hepatobiliary systems. He has delivered more than 100 invited lectures in international congresses and educational courses. He served as a member of the editorial board of European Radiology in the section of experimental radiology while he was a member of the abdominal subcommittee of ECR. He has been awarded two research scholarships from ECR.

Finally, he is an honorary member of the Spanish Society of Gastrointestinal Radiology (SEDIA). The main focus of his research is the development and validation of imaging biomarkers on cancer applications. He recently initiated the development of a Radiomics Network comprising luminary clinical sites in the US and Europe to advance research in that area of Radiomics. He is the section editor on AI, Radiomics, and Machine Learning in Cancer Imaging, and he is chairing the e-learning subcommittee of ICIS.

Ulrich Bick

Ulrich Bick is professor of radiology and vice-chairman in the department of radiology at the Charité - Universitätsmedizin Berlin since 2004. He is an internationally renowned expert in breast imaging and spokesperson of the center for hereditary breast and ovarian cancer in Berlin. His main research interests are digital mammography, computer-aided diagnoses and high-risk screening. He has authored or co-authored more than 100 peer-review publications, holds 6 patents, and has given numerous invited lectures, tutorials and refresher courses at national and international meetings. From 2008 to 2014 he was chairman of the board of the breast imaging group of the German Radiological Society and from 2012 to 2018 chairperson of the scientific committee and board member of the European Society of Breast Imaging. Since 2013, he is board member of the German Society of Senology.

Maryellen Giger

Maryellen L. Giger, Ph.D. is the A.N. Pritzker Professor of Radiology, Committee on Medical Physics, and the College at the University of Chicago.  She is also the Vice-Chair of Radiology (Basic Science Research) and the immediate past Director of the CAMPEP-accredited Graduate Programs in Medical Physics/ Chair of the Committee on Medical Physics at the University. 

For over 30 years, she has conducted research on computer-aided diagnosis, including computer vision, machine learning, and deep learning, in the areas of breast cancer, lung cancer, prostate cancer, lupus, and bone diseases. 

Over her career, she has served on various NIH, DOD, and other funding agencies’ study sections, and is now a member of the NIBIB Advisory Council of NIH.

She is a former president of the American Association of Physicists in Medicine, was the inaugural Editor-in-Chief of the SPIE Journal of Medical Imaging, and the 2018 President of SPIE (the International Society of Optics and Photonics). 

She is a member of the National Academy of Engineering (NAE) and was awarded the William D. Coolidge Gold Medal from the American Association of Physicists in Medicine, the highest award given by the AAPM.  She is a Fellow of AAPM, AIMBE, SPIE, SBMR, and IEEE, a recipient of the EMBS Academic Career Achievement Award, and is a current Hagler Institute Fellow at Texas A&M University.  In 2013, Giger was named by the International Congress on Medical Physics (ICMP) as one of the 50 medical physicists with the most impact on the field in the last 50 years.  IN 2018, she received the iBIO iCON Innovator award.

She has more than 200 peer-reviewed publications (over 300 publications), has more than 30 patents and has mentored over 100 graduate students, residents, medical students, and undergraduate students. 

Her research in computational image-based analyses of breast cancer for risk assessment, diagnosis, prognosis, and response to therapy has yielded various translated components, and she is now using these image-based phenotypes, i.e., these “virtual biopsies” in imaging genomics association studies for discovery.

She is a cofounder, equity holder, and scientific advisor of Quantitative Insights, Inc., which started through the 2009-2010 New Venture Challenge at the University of Chicago. QI produces QuantX, the first FDA-cleared, machine-learning driven system for cancer diagnosis (CADx).

 

Prof. Rowland Illing

Dr Rowland Illing is the Chief Medical Officer and Director of International Government
Health for Amazon Web Services (AWS). He has responsibility for public sector healthcare
strategy and operations for AWS internationally, excluding the US & China. This
encompasses healthcare service delivery, research and genomics. He is passionate about
the delivery of person-centred care, increasing access and improving outcomes at a lower
cost by accelerating the digitization and utilization of healthcare data.

Rowland is an Honorary Associate Professor at University College London, who trained in
both Cambridge and Oxford Universities. He is a Member of the Royal College of Surgeons
of England, Fellow of the Royal College of Radiologists and Senior Fellow of the Faculty of
Medical Leadership and Management in the UK. He continues to present and publish on
topics including digital healthcare and AI, is a member of the Digital Health Roster of Experts
for the WHO and member of the European AI Alliance for the European Commission.

Nicola Strickland

Dr Strickland is the current nationally elected President of the Royal College of Radiologists. She trained in Natural Sciences and Medicine at the University of Oxford. After gaining Membership of the Royal College of Physicians, she trained in Radiology at Hammersmith Hospital, and is now a Consultant Radiologist at Imperial College Healthcare NHS Trust in London. Her radiological specialist interests are chest and oncological body imaging, and imaging informatics. She has held a number of national and international leadership roles, including being President of MIR, Management in Radiology of the European Society of Radiology, President of the Radiological Section of the Royal Society of Medicine, Founder and Chairman of the Imaging Informatics Special Interest Group of the UK, and President of EuroPACS (a European imaging informatics society).

Sandy Napel

Dr. Napel was born in 1952 in New York City, NY and was educated in the New York City public school system. He obtained his Bachelor of Engineering Sciences from the State University of New York at Stony Brook, and his Masters of Science and Ph.D. degrees in Electrical Engineering at Stanford University in 1976 and 1981, respectively. He became an Assistant Professor in the Department of Radiology at University of California at San Francisco in 1981, and was a co-founder of Imatron, Inc., developer of the electron beam CT scanner, where he served as VP of Engineering. He joined the Department of Radiology at Stanford in 1991, where he is presently Professor, with courtesy appointments in Electrical Engineering and Medicine (Biomedical Informatics Research), and where he co-directs the Division of Integrative Biomedical Imaging Informatics at Stanford (IBIIS), and the Radiology 3D and Quantitative (3DQ) Imaging Laboratory. He has made contributions to the development of CT angiography, cardiac CT, visualization and quantitation of volumetric medical imaging data, computer-aided detection using medical imaging data and to the linkage of image features to genomics (radiogenomics). He holds 28 patents, has authored or co-authored over 140 peer-reviewed publications, 8 book chapters, and 300 presentations at National and International Meetings. He is a fellow of the American Institute for Medical and Biological Engineering (AIMBE) and a Distinguished Investigator in the Academy of Radiology Research.

 

Dr. Celso Matos

Celso Matos studied medicine at the Medical School of the University of Brussels, Belgium and obtained his Medical Degree Magna Cum Laude in 1980. After a fellowship in Internal Medicine and Rheumatology at the University of Brussels, he started his fellowship in Radiology at the department of Radiology at Erasme University Hospital in Brussels, Belgium in 1983.

As a board certified radiologist he joined the faculty in this department and led the MR imaging division since 1990. He became Professor of Clinical Radiology in 2001 at Erasme University Hospital. In late 2015 Celso Matos moved to Lisbon to start his current position as Head of the Imaging department at the Champalimaud Centre for the Unknown and co Director of Champalimaud Research for clinical investigation. 

Celso Matos has been President of the ESGAR (European Society for Abdominal and Gastrointestinal Radiology). 
As a radiologist he contributes to the imaging programme of several annual meetings and regularly co-organises radiological-clinical educational events.

Celso Matos’ main areas of clinical and research interest are abdominal and oncologic imaging. His main focus is multidisciplinary research in pancreatic cancer and related disorders.
Celso Matos has been part of the Abdominal Section of the European Radiology Editorial Board since 2014 and has been appointed Associate Editor of Radiology in November 2016.He received the European School of Radiology Best teacher Award in 2014.

 

Prof. Fred Prior

Fred Prior, Ph.D. is Distinguished Professor and Chair of the Department of Biomedical Informatics and Professor of Radiology at the University of Arkansas for Medical Sciences (UAMS).  Dr. Prior has extensive R&D experience in industry and academia, focused on the design of advanced medical information management and imaging technologies.  He has held senior management positions in a variety of R&D environments ranging from Silicon Valley startups to major multi-national corporations in the US and Europe.  

Dr. Prior’s research interests include cancer informatics, radiomics, and neuroimaging informatics. He serves as principle investigator and director of the US National Cancer Institute’s Cancer Imaging Archive project and is the lead PI of an NCI ITCR team exploring the integration of radiomics and pathomics. In 2021 Dr. Prior’s team joined a consortium of European colleagues to successfully compete for a Horizon 2020 award from the EU to develop a platform for distributed data management and machine learning to advance precision medicine in oncology.

Dr. Prior directs informatics efforts for the UAMS Translational Research Institute and Pediatric Clinical Trial Network. He is an associate editor of several leading scientific journals, and a reviewer for numerous scientific and engineering journals as well as U.S. and European funding agencies. He is the author of over 150 scientific publications and holds 6 US and international patents.

Prof. Charles Kahn

Dr. Charles Kahn is Professor and Vice Chairman of Radiology at the University of Pennsylvania.  He earned his Bachelor of Arts in Mathematics at the University of Wisconsin–Madison, his M.D. at the University of Illinois, and completed radiology residency at the University of Chicago, where he served as chief resident.  He earned a Master of Science in Computer Sciences from the University of Wisconsin in 2003.  He served on the faculty of the University of Chicago and the Medical College of Wisconsin before moving to his current position at Penn.  He is a Board-certified, practicing radiologist with expertise in body CT and ultrasound.  Professional interests include health services research, decision support, artificial intelligence, information standards, and knowledge representation.  He served two terms as Co-chair of the DICOM Standards Committee, and was 2012-2013 President of the American Roentgen Ray Society.  Honors include the Gold Medal of the American Roentgen Ray Society and elected Fellowship of the American College of Radiology, the American College of Medical Informatics, and the Society for Imaging Informatics in Radiology.  He is author of more than 110 scientific publications, and has given more than 100 invited lectures.  He is the Editor of RSNA’s new journal, Radiology: Artificial Intelligence.    

Seong K. Mun

Seong K. Mun, PhD, is a professor and director of Arlington Innovation Center: Health Research at Virginia Tech, Arlington, VA, and engaged in research in artificial intelligence, health informatics, medical imaging, and patient safety for radiation oncology. He is also a senior imaging scientist for the Apollo Cancer Program involving the Department of Defense, Department of Veterans Affairs, and National Cancer Institute.

Dr. Mun is the founding President and CEO of Open Source Electronic Health Record Alliance (OSEHRA), established by the Department of Veterans Affairs in 2011 as a not-for-profit organization to promote open source innovations in health IT.

During the '80s and '90s, he was at Georgetown University Medical Center as Director of Imaging and Information Systems (ISIS) Center, where he championed the development of filmless radiology (a.k.a. PACS), global teleradiology, telemedicine, medical robotics, combat casualty care, and global disease surveillance. 

He received his PhD in physics from the State University of New York and completed an NIH medical physics fellowship at the Department of Radiology, University of Colorado Medical School. 

 

Jayashree Kalpathy-Cramer

Jayashree Kalpathy-Cramer is an Associate Professor of Radiology at MGH/Harvard Medical School. She is an electrical engineer by training, having received her B.Tech from the Indian Institute of Technology, Bombay, India and  her PhD at Rensselaer Polytechnic Institute in Troy, NY. After working for almost a decade in the semiconductor industry, a desire to apply engineering principles and data science to healthcare put her on a path back to academia. Currently, her interests in machine learning and AI permeate her research in quantitative medical imaging. Her work spans the spectrum from theoretical algorithm development to clinical translation. She is a co-director of the Quantitative Translational Imaging in Medicine (QTIM) lab and the Center for Machine Learning at the Athinoula A. Martinos Center for Biomedical Imaging at MGH where she supervises PhD students and mentors post-doctoral fellows and research scientists.

Her lab is actively involved in the applications of AI to problems in oncology, radiology and ophthalmology. Consulting with clinical collaborators, they identify problems where current technical advances such as deep learning have the potential to impact patient care in the near term. These include disease detection, classification, risk stratification and prediction of response to therapy. In oncology, they have developed automated algorithms to quantify tumor burden, non-invasive prediction of tumor mutation status and quantitative imaging predictors of response to therapy.

Dr. Kalpathy-Cramer has authored over 100 scientific publications, holds 12 patents and has delivered numerous invited lectures and tutorials at national and international meetings. She is a Deputy Editor for the newly launched Radiology: Artificial Intelligence journal published by RSNA.

Antonio Criminisi

Antonio Criminisi
Principal Researcher

In 2000 Antonio Criminisi obtained his doctorate degree (PhD) in computer vision from the University of Oxford. In June 2000 Antonio joined the Machine Learning and Perception group at Microsoft Research in Cambridge as a visiting researcher. In February 2001, he moved to the Interactive Visual Media Group in Redmond (WA, USA) as a post-doctorate researcher. In October 2002, he moved back to the Microsoft Research Cambridge as a Researcher. In 2014, he became Principal Researcher and is now leading Project InnerEye, to develop a tool for assistive AI for cancer treatment.
Antonio has written and co-authored numerous scientific papers and books on machine learning for the analysis of radiological images, decision forests, deep learning and convolutional neural networks, object recognition, image and video analysis and editing, videoconferencing, 3D reconstruction and virtual/augmented reality, forensic science and history of art.

Antonio’s research has been awarded a number of best paper prizes at top computer vision and machine learning conferences, amongst which the prestigious David Marr prize at ICCV 2015 for his paper “Deep Neural Decision Forests”.

Background

Antonio Criminisi was born in 1972 in Italy. In October 1990 he was appointed "Alfiere del Lavoro" by the Italian President F. Cossiga for his successful studies. In July 1996 he received a Degree in Electronics Engineering at the University of Palermo and in December 1999, he obtained a "Doctor of Philosophy" (PhD) Degree in Computer Vision at the University of Oxford. His thesis “Accurate Visual Metrology from Single and Multiple Uncalibrated Images” won the British Computer Society Distinguished Dissertation Award for the year 2000 and was published by Springer-Verlag London Ltd. in August 2001. Antonio was a Research Fellow at Clare Hall College, Cambridge from 2002 to 2005.

Eric Van Cutsem

Eric Van Cutsem, MD, PhD   
University Hospitals Leuven

Eric Van Cutsem, MD, PhD, is professor at the University of Leuven, Belgium, since 2000. He is head of the division of Digestive Oncology at the University Hospitals Gasthuisberg Leuven (UZ Leuven) and University of Leuven (KUL).

Professor Van Cutsem became doctor honoris causa of the Medical University of Warsaw, Poland in June 2018. He is member of the Belgian Royal Academy of Medicine since 2015 and president of the Belgian Foundation Against Cancer since October 2016.
Prof Van Cutsem obtained his medical degree in 1983 from the University of Leuven, where he specialized in internal medicine and gastroenterology and he was awarded his PhD in 1994. 

Prof Van Cutsem has published 547 peer-reviewed articles (PubMed, Jan 2019), 1114 articles in Web of Science, Thomson Reuters (h-factor: 114; >61700 citations). His work has been published in the most respected publications such as the New England Journal of Medicine, The Lancet, Lancet Oncology, JAMA, Journal of Clinical Oncology, Nature Reviews Clinical Oncology, Annals of Oncology, European Journal of Cancer, British Journal of Cancer, and Gastroenterology.
In 2013, Prof Van Cutsem was mentioned in Capital (a French magazine) amongst the top 3 reputed colon cancer experts in the world and is mentioned in Thomson Reuters within the 1% highest impact in his domain (http://highlycited.com/). He also coordinates several European and worldwide trials investigating new drugs for gastrointestinal cancer and he serves on many steering committee and advisory boards.
 
Prof Van Cutsem is a member of several scientific organizations. He is/was a member of the scientific program committee and/or educational committee of ASCO, ASCO-GI cancers symposium, ESMO, UEG, and ECCO. He served for ESMO as executive board member from 2011 to 2013 and since 2014 is on the ESMO press committee. He was secretary from 2000 to 2003, chair of the EORTC-GI group from 2003 to 2007, and is chairman of PETACC (Pan-European Trials on Adjuvant Colon Cancer) since 2008. He was board member of the EORTC from 2009 to 2015 and is president of European Society of Digestive Oncology (ESDO) as well as co-chairman of the European Neuro-Endocrine Tumour Society (ENETS) registry. 
He was chairman of the governmental colon cancer prevention task force in Flanders, Belgium and was president of BGDO (Belgian Group Digestive Oncology) from 2010 to 2016. He was president of FAPA (Familial Adenomatous Polyposis Association) until 2016 and is now vice-president of FAPA and is member of the general assembly of Kom tegen Kanker (Flemish Cancer League). He is medical director of Europacolon (a patient advocacy group).
Prof Van Cutsem is the founder of (1999) and is also the chair of the scientific committee of the ESMO GI/World Congress on Gastrointestinal Cancer in Barcelona, Spain (in partnership with ESMO since 2005), which is the largest meeting on GI cancer with >3500 participants.

Heinrich von Busch

Heinrich von Busch, PhD, Product Owner Artificial Intelligence for Oncology at Siemens Healthineers

Heinrich von Busch studied physics at the universities of Bonn, Heidelberg and Kaiserslautern. He received a diploma in 1992 with experimental work on the measurement of the rare quantum-electrodynamical positronium decay mode into 4 photons, and a PhD in 1998 with a thesis on the analysis of pseudorotation in the sodium trimer by high-resolution laser spectroscopy.

In 1999, Heinrich joined Philips Research, where he worked on mercury-free lamps for UV water disinfection before turning to medical topics in 2003, in research for nuclear medical imaging. As a senior scientist, he led a research project on improvements in prostate cancer care, and took over a business development role on the same topic with Philips Healthcare in 2008. Heinrich continued his activities at the intersection of oncology and medical imaging at Siemens from 2011 in outbound and inbound segment management positions for magnetic resonance imaging for oncology. In his current role, he is responsible for several innovation projects in AI for medical image interpretation.

Jorge Soares

• Director, Calouste Gulbenkian Foundation (Gulbenkian Programme for Knowledge)

• Professor of Pathology, University of Lisbon (-2013)

• Director, Institute of Legal Medicine and Forensic Sciences (Lisbon), 2001-03

• Director, Department of Pathology, Lisbon Cancer Center, 1985-2001

• President, Sociedade das Ciências Médicas de Lisboa, 2003-05, Sociedade Portuguesa de Anatomia Patológica, 1997-99, Sociedade Portuguesa de Senologia, 2004-06

• Full Member, Academia de Medicina de Portugal, Associated Member, Real Academia Nacional de Medicina de España, Real Academia de Medicina de Granada, Academia das Ciências de Lisboa

• President, National Council of Bioethics for Life Sciences, 2016-

• Vice-President, Ethics Comission, Champalimaud Foundation (-2016)

• Chair, Scientific Council for Health and Life Sciences, FCT 2013-4

• Award Gold Medal, Ministry of Health

Dr. Tristan Barrett

Dr. Audrey Jacques

Prof Dietmar Tamandl

Dr Stephan D. Voss

Mr. Andrew Hall ( Honorary Treasurer )

Andrew Hall has worked at a senior level in major, UK-wide and international professional membership bodies for over 30 years. His experience ranges across developing strategies, growing capability and capacity, managing and developing governance, member relationships and engagement, policy and stakeholder engagement and major developmental projects.

Andrew started his career in local government which included a strong focus on governance before moving to the Law Society of England and Wales where he occupied a series of managerial roles pivotal to the organisation’s co-ordination and management.

Moving to the health sector, Andrew took up a role at the Royal College of General Practitioners focusing on external engagement and governance and was ultimately Deputy Chief Executive. Andrew then spent 17 years as Chief Executive of the Royal College of Radiologists which grew significantly in terms of membership size, capacity and capability under his leadership.

Andrew is now working in a freelance capacity assisting membership bodies drawing on his wealth of experience and knowledge.

Trevor Pereira

Louise Mustoe

Steve Howard

Dr. Brent Little

Prof. Marc Zins

Maarten de Rooij

Prof. Paris Tekkis

Prof Eric Ruiller

Dr. Matthew Blackledge

Dr Matthew Blackledge is conducting a three-year independent research project on medical image analysis of bone metastasis at The Institute of Cancer Research, London.

Dr Blackledge's research seeks to provide clinical imaging methodologies for evaluating and understanding response mechanisms associated with novel therapeutics for bone metastases. Dr Blackledge collaborates with Professor Martin Leach, David Collins and Dr Dow-Mu Koh within the Cancer Research UK Cancer Imaging Centre at the ICR, which provides a unique opportunity to investigate techniques that can be quickly translated for the clinical management of patients in The Royal Marsden.

Bone metastases arising from a range of primary tumour sites have severe consequences for the patient, and although many new treatments are becoming available, there is currently no standard technique for early stage detection of response. Dr Blackledge is hoping to uncover novel imaging methodologies that incorporate whole-body MRI in conjunction with PET/CT and innovative image analysis techniques to provide a biological map of areas of response throughout the body during treatment. These techniques provide a rich data set of quantitative information including tumour volume, tumour cellularity, tumour metabolism and bone status that can indicate regions of response and provide image-guided treatment for patients.
Dr Blackledge is also working on new statistical techniques to quantify and visualise regions of heterogeneous response to treatment. Recent studies have clearly identified differences in the evolution pattern between distinct metastases throughout the body. The genomic differences in these mutated lesions can lead to differential treatment resistance. By using medical imaging techniques such as MRI and PET/CT it is possible to non-invasively probe individual metastases, allowing quantitative evaluation and visualisation of heterogeneous response throughout the body.

 

Dr. Jorge Cardoso

M Jorge Cardoso is Senior Lecturer in Artificial Medical Intelligence at King’s College London, where he leads a research portfolio on big data analytics, quantitative radiology and value based healthcare. Jorge is also the CTO of the new London Medical Imaging and AI Centre for Value-based Healthcare.

Prior to King’s, Dr Cardoso was a Lecturer at UCL, Technical Lead of the Quantitative Radiology Initiative at the National Hospital for Neurology and Neurosurgery (NHNN), and Engineering Lead of the Neuro-oncology Flagship Programme at UCL, Institute of Healthcare Engineering.

He has more than 12 years expertise in advanced image analysis, big data, and artificial intelligence, and co-leads the development of NiftyNet, a deep-learning platform for artificial intelligence in medical imaging. He is also a founder of BrainMiner, a medtech startup aiming to bring quantitative biomarkers and predictive models to neurological care.

 

Dr. Florent Chandelier

Florent Chandelier provides technical oversight for the ai4gi joint venture with over 10 years experience in the field of Artificial Intelligence applied to Medical Imaging. Florent serves as Chief Technology Officer for Imagia Cybernetics Inc in Montreal which focuses on the application of Artificial Intelligence to cancer detection and diagnosis. Florent Chandelier is a co-founder of Cadens Medical Imaging where he managed strategic alliances and the development of innovative and market-driven products, including navigating critical regulatory concerns.

Dr. Chandelier is a member of the Intellectual Property Canadian International Council, a Canadian business coalition, supported by the Canadian Chamber of Commerce, designed to provide a central voice to press for stronger intellectual property protection both in Canada and worldwide.
He holds a Ph.D. in Mechanical Engineering from the University of Sherbrooke and a Master’s in Medicine & Medical Imaging from Paris Sud.

 

Dr. Mireia Crispin-Ortuzar

Mr. Simon Doran

Dr. Bradley Erickson

Bradley J Erickson, MD PhD, received his MD and PhD degrees from Mayo Clinic. He went on to be trained in radiology, and then completed a Neuroradiology fellowship at Mayo, and has been on staff at Mayo since 1994. He continues to practice Neuroradiology, but has also served in other roles, including chair of the Radiology Informatics Division, Associate Chair for Research, and the Scientific Director for AI. He now serves as the Director for AI at Mayo Clinic, focusing on helping clinical areas develop and implement AI tools into their practices. He has been awarded multiple external grants, including NIH grants on MS, brain tumors, polycystic kidney disease, and medical image exchange. He is a former president of the Society of Imaging Informatics in Medicine, was Chair of the American Board of Imaging Informatics, was on the Board of the IHE USA and chairs the External Advisory Board of the Imaging Data Commons. He recently won the nVIDIA Global Impact Award for his work on deep learning applications in medical images.

Mr. John Freymann

John Freymann is the Director of the Cancer Imaging Informatics Lab, part of the Frederick National Lab for Cancer Research at the US National Cancer Institute.   John's focus is on accelerating the contribution imaging data can make to cancer research by providing infrastructure for data sharing and by directing the imaging components of several NCI multi-omic cancer research programs.    His lab's flagship activity is The Cancer Imaging Archive,  an open data archive which provides the research community with high quality curated imaging collections with low or no barriers to access. 

Dr. Henkjan Huisman

Henkjan Huisman is associate professor of radiology on AI for medical imaging at the Radboud University Medical Center, The Netherlands. He has over 30 years of experience in scientific research, prototyping , and clinical validation of medical imaging AI. His research team explores and uses AI to better understand disease, diagnosis, and therapy in the field of abdominal ultrasound and MRI aiming to improve healthcare. 

Prof. Curt Langlotz

Dr. Langlotz is Professor of Radiology and Biomedical Informatics and Director of the Center for Artificial Intelligence in Medicine and Imaging (AIMI Center) at Stanford University, which conducts interdisciplinary machine learning research that optimizes how clinical images are used to promote health.  He is also responsible for the computer technology that supports the Stanford Radiology practice.  

As a graduate student in computer science, Dr. Langlotz was a member of the team that implemented the first AI system in clinical practice.  He has led many national and international efforts to improve radiology, including the RadLex™ terminology standard, the RadLex™ Playbook of radiology exam codes, the RSNA report template library, and a national COVID-19 imaging repository. He has published over 100 scholarly articles, and is author of the 2015 book “The Radiology Report: A Guide to Thoughtful Communication for Radiologists and Other Medical Professionals”.  
Raised in St. Paul, Minnesota, Dr. Langlotz received his undergraduate degree in Human Biology, masters in Computer Science, MD in Medicine, and PhD in Medical Information Science, all from Stanford University. He currently serves on the Board of Directors of the Radiological Society of North America (RSNA) as Liaison for Information Technology. He has founded three healthcare information technology companies, most recently Montage Healthcare Solutions, which was acquired by Nuance Communications in 2016.

 

Dr. Ben Newton

As Global Head of Oncology Solutions at GE Healthcare, Dr Ben Newton is focused on enabling the earlier diagnosis of cancer, leading to better care and better outcomes. GE Healthcare’s technology is used all along the patient’s journey, from screening, diagnosis and staging of the cancer, through treatment planning, monitoring and follow-up.

During a 25-year career in roles spanning R&D, commercial and general management, Dr Ben Newton has led numerous drug, diagnostic and prognostic products from conception to commercialisation. He has led innovative and entrepreneurial businesses at GE Healthcare in areas such as Ultrasound, Molecular Imaging, Digital and now Oncology Solutions. Prior to his current role, Ben was Chief Digital Officer of GE Healthcare’s Life Science business. He previously held leadership positions in Molecular Imaging, Ultrasound, Product Management and R&D.
GE Healthcare is a $17 billion business that provides a broad portfolio of products, solutions, software and services used in the diagnosis, treatment and monitoring of patients.

 

Dr. Nicholas Petrick

Prof. Joel Saltz

Dr. Joel Saltz is a leader in research on advanced information technologies for large scale data science and biomedical/scientific research. He has developed innovative pathology informatics methods, including: the first published whole slide virtual microscope system; pioneering pathology computer-aided diagnosis techniques; and methods for decomposing pathology images into features and linking those features to cancer “omics”, response to treatment and outcome. He has broken new ground in big data through development of the filter-stream based DataCutter system, the map-reduce style Active Data Repository and the inspector-executor runtime compiler framework. He has also been an active contributor in clinical informatics, having developed predictive models for hospital readmissions, point of care laboratory testing quality assurance systems, decision support systems for electrophoresis interpretation and graphical user interfaces to support clinical data warehouse queries. Dr. Saltz has been a pioneer in establishing the field of biomedical informatics; he founded and built two highly successful departments of biomedical informatics, one at Ohio State University and one at Emory University. In 2013, he came to Stony Brook as Vice President for Clinical Informatics and Founding Department Chair of Biomedical Informatics – to create a living laboratory for biomedical informatics and to create a third unique biomedical informatics department dually housed in the School of Medicine and the College of Engineering. Dr. Saltz is trained both as a computer scientist and as a physician through the MSTP program at Duke University. He has deep experience in computer science, having served on the computer science faculties at Yale University and the University of Maryland. He completed his residency in clinical pathology at Johns Hopkins University and he is a practicing, board-certified clinical pathologist. 
 
In 2021, Dr. Joel Saltz has been appointed as Vice Chair for Laboratory Initiatives and Digital Medicine in the Department of Pathology.

 

Prof. Neil Sebire

Dr. Ramona Woitek

Dr Ramona Woitek is a Senior Research Associate and Honorary Consultant Radiologist in the Department of Radiology of the University of Cambridge. Her research on breast and ovarian cancer focuses on metabolic imaging for early response assessment and on multimodal data integration for radiogenomics studies. She has authored over 50 medical research articles.

Ramona Woitek finished her undergraduate studies in Medicine in 2008 followed by a PhD and radiology specialty training at the Medical University of Vienna, Austria and joined the University of Cambridge, UK, in 2017.

 

Dr. Michael Hoffman

Prof. Aurelius Omlin

Prof. Michael Hofman

Dr. Paola Clauser

Dr. Subba R. Digumarthy

Dr. Kyung Won Kim

Dr. Atul B. Shinagare

Dr. Priyanka Jha

Prof. Davide Farina

Dr. Fiona Fennessy

Prof. Bachir Taouli

Prof. Annick D. Van den Abbeele ( Joint Editor-in-Chief, Cancer Imaging )

Annick D. Van den Abbeele, MD, FACR, FICIS

Professor Van den Abbeele is Professor of Radiology at Harvard Medical School; Chair Emeritus, Department of Imaging, Founder and Director of the Center for Biomedical Imaging in Oncology, Dana- Farber Cancer Institute; Co-Director of the Tumor Imaging Metrics Core, Dana-Farber/Harvard Cancer Center; Chief Emeritus, Division of Cancer Imaging, Department of Radiology, Mass General Brigham; and Senior Faculty Scholar, Dana-Farber Cancer Institute and Mass General Brigham.

Professor Van den Abbeele was recently elected the 2021-2022 President of the International Cancer Imaging Society (ICIS) and serves as co-Editor-in-Chief of the ICIS journal, Cancer Imaging. She is nationally and internationally known for her translational research in molecular imaging, building upon her pioneering work in using imaging to monitor target hit and response to molecularly-targeted therapy and immunotherapy in several cancers. Professor Van den Abbeele is the founder and director of the Center for Biomedical Imaging in Oncology, an integrated clinical and preclinical cancer imaging center co-located with a research-dedicated state-of-the-art cyclotron. She also co-founded and co- directs the Tumor Imaging Metrics Core now established at eight national comprehensive cancer centers. Professor Van den Abbeele has participated in multiple trials testing novel diagnostic and therapeutic agents and helped implement the field of theranostics in multiple cancers. She launched cancer imaging as a new imaging specialty, and the Cancer Imaging Program Fellowship which has grown from one fellow to nine fellows currently who are themselves creating cancer imaging divisions in their own departments.

Her major areas of research include translational cancer research using molecular imaging using multidisciplinary integrated pre-clinical and clinical programs, and quantitative tumor imaging metrics. Professor Van den Abbeele is a Fellow of the American College of Radiology (FACR) and of the International Cancer Imaging Society (FICIS). She has received several awards, serves on various national and international scientific advisory boards and review panels, NCI program progress review groups, and several local, national and international committees. Professor Van den Abbeele has mentored over 200 trainees; serves as a PhD thesis advisor, reviewer and faculty mentor; has authored and co-authored more than 300 scientific articles, abstracts, educational materials, book chapters; co- edited 2 textbooks; and presented numerous lectures and workshops nationally and internationally.

Dr. Katherine Krajweski

Dr. Amir Iravani

Dr. Geetika Khanna

Prof. Valeria Panebianco

Prof. Vikas Gulani

Prof. Ken Herrmann

Dr. Elaine Lee

Dr. Maarten Lequin

Prof. Max Wintermark

Dr Patrick Asbach

Dr Masako Kataoka

Prof. Dr. med. Thorsten Persigehl ( Deputy Editor, Cancer Imaging )

Prof. Dr. Thorsten Persigehl will support the Journal Cancer Imaging as Deputy Editor from April 2024.

Prof. Persigehl holds the professorship of Oncological Imaging and he is Vice-chair at the Department of Diagnostic and Interventional Radiology at the University Hospital of Cologne. The University Hospital of Cologne with his center of integrated oncology (CIO) is one of the largest comprehensive cancer centers in Germany.

As part of his clinical work, he is responsible for oncological imaging in general radiology with special expertise in abdominal imaging. Recently he founded the radiological CIO (radCIO) to reflect the increasing specialization and digitalization in radiology, supported by the EU program EFRE.

As part of his scientific focus, Prof. Persigehl is investigating, with funding from German Cancer Aid (DKH), how standardized reports can be created in radiology so that this data is available digitally for clinical patient care and oncological research. On the other hand, he is developing algorithms for artificial intelligence (AI) to automatically detect and segment lymph nodes in CT images, determine their anatomic localization as part of the German Research Foundation (DFG) Priority Program 2177. Another focus is on developing and testing AI algorithms that automatically search CT images for signs of an infection that could be linked to COVID-19.

In the years 2010 and 2011, he stayed as postdoctoral researcher in the oncological research group of Prof. Lawrence Schwartz at Columbia University Medical Center (CUMC) in New York. Since 2017 he is elected fellow der International Cancer Imaging Society (ICIS) and since 2022 master of oncological imaging (ESOI). Prof. Persigehl is former chairman of the Oncological Working Group of the German Society of Radiology (DRG) and speaker of the Oncological Working Group (ABO) of the German Cancer Foundation (DKG).

He is currently involved as author and co-author in over 180 research papers, reviews and book chapters.

Dr. Nina Tunariu

Dr. Christina Messiou

Dr Mathilde Wagner

Dr. Maria Antonietta Bali

Dr Jolanta Kunikowska

Dr Thorsten Persigehl

Prof. Lennart Blomqvist